Table 4.
p-Value Anova (Effect Size f2%) | p-Value (SBPRE vs. PLAPRE) | SBPRE | SBPOST | p-Value (SBPRE vs. SBPOST) | PLAPRE | PLAPOST | p-Value (PLAPRE vs. PLAPOST) | p-Value (SBPOST vs. PLAPOST) | ||
---|---|---|---|---|---|---|---|---|---|---|
Glucose (mg∙dL−1) | Pre-exercise | 0.4848 (0.7%) | 1.0000 | 118.3 ± 16.6 (110.3–125.9) | 102.6 ± 20.5 (96.3–115.5) | 0.1060 | 124.2 ± 19.9 (114.9–133.6) | 113.0 ± 14.9 (106.0–119.9) | 1.0000 | 1.0000 |
Post-exercise | 1.0000 | 139.3 ± 24.0 (125.6–146.9) | 130.9 ± 25.7 (109.1–133.8) | 1.0000 | 135.0 ± 24.1 (123.7–146.3) | 131.4 ± 22.5 (120.9–142.0) | 1.0000 | 1.0000 | ||
Lactate (mmol∙L−1) | Pre-exercise | 0.2044 (1.4%) | 1.0000 | 1.56 ± 0.42 (1.40–1.73) | 1.51 ± 0.40 (1.30–1.75) | 1.0000 | 1.68 ± 0.46 (1.56–2.40) | 1.67 ± 0.57 (1.44–2.19) | 1.0000 | 1.0000 |
Post-exercise | 1.0000 | 16.37 ± 2.25 (15.57–17.62) | 16.82 ± 2.82 (13.72–16.98) | 1.0000 | 15.98 ± 2.73 (14.58–17.19) | 15.77 ± 2.65 (14.12–17.02) | 1.0000 | 1.0000 |
Values are means ± SD (and 95% confidence intervals). Abbreviations: SBpre—before sodium bicarbonate supplementation, SBpost—after sodium bicarbonate supplementation, PLApre—before placebo treatment, PLApost—after placebo treatment.